| Primary |
| Bladder Cancer |
79.1% |
| Bladder Transitional Cell Carcinoma |
4.1% |
| Bladder Cancer Stage 0, With Cancer In Situ |
3.1% |
| Transitional Cell Carcinoma |
2.6% |
| Carcinoma In Situ Of Bladder |
2.0% |
| Bladder Transitional Cell Carcinoma Recurrent |
1.5% |
| Accidental Exposure |
1.0% |
| Bladder Neoplasm |
1.0% |
| Immunisation |
1.0% |
| Malignant Neoplasm Of Renal Pelvis |
1.0% |
| Benign Prostatic Hyperplasia |
0.5% |
| Bladder Cancer Recurrent |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Hypertension |
0.5% |
| Hyperuricaemia |
0.5% |
| Lipid Metabolism Disorder |
0.5% |
| Rheumatoid Arthritis |
0.5% |
|
| Pyrexia |
22.5% |
| Weight Decreased |
13.5% |
| Bovine Tuberculosis |
9.0% |
| Vomiting |
8.1% |
| Pollakiuria |
3.6% |
| Prostatic Abscess |
3.6% |
| Reiter's Syndrome |
3.6% |
| Tuberculosis |
3.6% |
| Lumbar Spinal Stenosis |
2.7% |
| Orchitis |
2.7% |
| Pancreatic Mass |
2.7% |
| Prostatomegaly |
2.7% |
| Red Blood Cell Sedimentation Rate Increased |
2.7% |
| Renal Mass |
2.7% |
| Respiratory Failure |
2.7% |
| Scrotal Swelling |
2.7% |
| Sepsis |
2.7% |
| Testicular Pain |
2.7% |
| Testicular Swelling |
2.7% |
| Vascular Pseudoaneurysm |
2.7% |
|
